ProfileGDS4718 / 205507_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 64% 63% 74% 63% 63% 62% 68% 64% 65% 63% 63% 65% 67% 68% 66% 63% 66% 69% 69% 84% 65% 64% 63% 64% 66% 64% 67% 64% 64% 69% 65% 70% 67% 64% 67% 68% 68% 65% 67% 74% 66% 72% 69% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4176464
GSM549102patient 115, normal, homogenized [OPG study]6.3047763
GSM549104patient 119, normal, homogenized [OPG study]7.2938574
GSM549108patient 138, normal, homogenized [OPG study]6.3196363
GSM549119patient 077, normal, homogenized [OPG study]6.3084663
GSM549133patient 032, cancer, homogenized [OPG study]6.234162
GSM549139patient 042, cancer, homogenized [OPG study]6.6975568
GSM549099patient 107, normal, homogenized [OPG study]6.3608164
GSM549109patient 139, normal, homogenized [OPG study]6.4688265
GSM549110patient 046, normal, homogenized [OPG study]6.3246463
GSM549114patient 063, normal, homogenized [OPG study]6.2644763
GSM549122patient 082, normal, homogenized [OPG study]6.5025365
GSM549134patient 033, cancer, homogenized [OPG study]6.6434367
GSM549136patient 036, cancer, homogenized [OPG study]6.7060368
GSM549140patient 044, cancer, homogenized [OPG study]6.5833666
GSM549111patient 047, normal, homogenized [OPG study]6.346263
GSM549113patient 057, normal, homogenized [OPG study]6.5640266
GSM549132patient 031, cancer, homogenized [OPG study]6.8299469
GSM549137patient 038, cancer, homogenized [OPG study]6.7818869
GSM549142patient 047, cancer, homogenized [OPG study]8.0310984
GSM549100patient 110, normal, homogenized [OPG study]6.4412765
GSM549107patient 135, normal, homogenized [OPG study]6.3874164
GSM549115patient 068, normal, homogenized [OPG study]6.3201763
GSM549116patient 072, normal, homogenized [OPG study]6.3940464
GSM549120patient 078, normal, homogenized [OPG study]6.5693266
GSM549131patient 030, cancer, homogenized [OPG study]6.3868264
GSM549118patient 074, normal, homogenized [OPG study]6.6325167
GSM549129patient 027, cancer, homogenized [OPG study]6.4742764
GSM549123patient 088, normal, homogenized [OPG study]6.3927964
GSM549124patient 006, cancer, homogenized [OPG study]6.7193569
GSM549126patient 015, cancer, homogenized [OPG study]6.4990865
GSM549128patient 025, cancer, homogenized [OPG study]6.9799170
GSM549103patient 117, normal, homogenized [OPG study]6.5944867
GSM549117patient 073, normal, homogenized [OPG study]6.3365564
GSM549138patient 041, cancer, homogenized [OPG study]6.6827367
GSM549141patient 045, cancer, homogenized [OPG study]6.7807368
GSM549130patient 028, cancer, homogenized [OPG study]6.6604668
GSM549101patient 111, normal, homogenized [OPG study]6.5104265
GSM549105patient 128, normal, homogenized [OPG study]6.646567
GSM549106patient 134, normal, homogenized [OPG study]7.3375474
GSM549112patient 048, normal, homogenized [OPG study]6.5398466
GSM549125patient 011, cancer, homogenized [OPG study]7.0438672
GSM549127patient 024, cancer, homogenized [OPG study]6.901369
GSM549135patient 035, cancer, homogenized [OPG study]6.511665